Assessing the Role of Soft Contact Lenses in Preoperative Conditions Following Keratoprosthesis Implantation The authors have no financial interest in.

Slides:



Advertisements
Similar presentations
Evaluation of Higher Order Aberrations in Eyes with Dohlman/Boston Keratoprosthesis and Comparison with Penetrating Keratoplasty and Normal Eyes K.Stasi.
Advertisements

Overnight Corneal Reshaping (Orthokeratology) in Adolescents S. Lance Forstot, MD, FACS The author has no financial interest in the subject matter of this.
Therapeutic Penetrating Keratoplasty in Fungal Keratitis: Prospective Study Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
17278 Prosthetic Replacement in Steven-Johnson Syndrome Varsha Rathi Somasheila I Murthy L V Prasad Eye Institute, Hyderabad, India The authors have no.
Sérgio Kwitko, Tiago Lansini, Andressa P Stolz, Diane R Marinho Authors have no financial interest in the subject matter of this poster.
Clinical Associate Professor Department of Ophthalmology Loyola University at Chicago, U.S.A. Visiting Professor Department of Defense, Military Medical.
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Use of a Novel Y- Suture Technique to Reduce Detachments in Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) Habeeb Ahmad, MD Martin Heur,
The authors have no financial interests to disclose
Corneal melting after collagen cross-linking for keratoconus Journal of Medical Case Reports,2011 By Ibrahim almahuby Dr.Georgios Labiris.
Cecilia M Cavalcanti Roberta Ventura Bernardo M Cavalcanti Ronald F Cavalcanti Demographic Profile of Corneal Transplantation patients over the past 20.
ETIOLOGY OF KERATOPROSTHESIS LOSS: RESULTS FROM THE BOSTON KERATOPROSTHESIS MULTICENTER STUDY J.B. Ciolino, MD; J.D. Ament, MD; B.L. Zerbe, MD; M. W. Belin,
The authors have no financial disclosures relevant to the topic.
Relationship Between Donor Graft Cell Count and Visual Outcome in DSAEK Patients Authors Silvin Bakalian MD PhD, Johanna Choremis MD FRCSC, Michele Mabon.
Nursing Management: Visual and Auditory Problems
Assessment and Management of Patients With Eye and Vision Disorders
Boston Type I Keratoprosthesis and Silicone Oil for the Treatment of Hypotony in Prephthisis Kristiana D. Neff 1, William I. Sawyer 2, Michael R. Petersen.
Outcome of refractive surgery in keratoconus suspect eyes
Elvin H. Yildiz, Elisabeth J. Cohen, Ajoy S. Virdi, Kristin M. Hammersmith, Peter R Laibson, and Christopher J. Rapuano Cornea Service, Wills Eye Institute,
CONTACT LENSES. CONTACT LENSES CONTACT LENSES.
Management of Methicillin- Resistant Staphylococcus Aureus Keratitis in Post-surgical Patients: Two Case Reports Sujata P. Prabhu, MD and Timothy Y. Chou,
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Modified Postoperative Regimen to Increase Retention of Keratoprostheses Juan Carlos Abad, MD Private practice, Medellín - Colombia Carolina Gómez Calle,
April 15-17, 2015 World Cornea Congress VII San Diego, California
Dr. K.S.SIDDHARTHAN Aravind Eye Hospital Coimbatore
Somasheila I. Murthy, Prashant Garg, Pravin K. Vaddavalli
Ahmad Kheirkhah MD, Rodrigo Muller MD, Deborah Pavan-Langston MD, Andrea Cruzat MD, Pedram Hamrah MD Ocular Surface Imaging Center, Massachusetts Eye and.
Evaluation of Epithelial Changes in Limbal Stem Cell Deficiency Using in Vivo Confocal Microscopy ERIC CHAN, Luxia Chen, Sophie X. Deng Cornea and Uveitis.
Retinal Detachment after Keratoprosthesis Placement: Incidence, Predisposing Factors, and Visual and Anatomic Outcomes M. Stephanie R. Jardeleza, M.D.
Prof. A. John Kanellopoulos, MD 1 Long-term Safety and Efficacy of High-Fluence Collagen Crosslinking of the Vehicle Cornea in.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Outcome of therapeutic keratoplasty in fungal keratitis Sonika Gupta, MS Assistant Professor, GMCH, Chandigarh, India Author has no financial interest.
Restoration of vision after alkali burn in 11 year old boy
Evaluation of Systane® versus Placebo in Corneal Epithelial Healing Following Photorefractive Keratectomy (PRK) Lt Col Charles D. Reilly Major Vasudha.
INTACS – PKP Comparison X X 180°-0.75 TransplantIntacs.
CASE IV CORNEAL HYDROPS.
Visual Outcomes After Temporary Keratoprosthesis Kristin C. Bains, MD Robert Phillips, MD The authors have no financial interest in the subject matter.
Short Term Visual Outcomes Boston Keratoprosthesis Type I
Indications for and Outcomes of Therapeutic Penetrating Keratoplasty Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author has no.
AlphaCor TM : A Novel Approach to Minimize Late Post-operative Complications V. Ngakeng MD, M. Price PhD. MBA, F. Price MD.
INSTITUTO DE OJOS Dr. HUGO DANIEL NANO Buenos Aires, Argentina No financial disclosures to discuss.
Deep anterior lamellar keratoplasty in children World Cornea Congress April 2010 Boston, MA Asim Ali, MD, FRCSC University of Toronto Hospital for Sick.
Severity of Herpes Zoster Ophthalmicus: Onset at Younger Than 60 Years Versus 60 Years or Older Neelofar Ghaznawi MD, Ajoy Virdi MD, Amir Dayan, Christopher.
Sergio Kwitko, Andressa P. Stolz, Melissa Dal Pizzol, Diane Marinho, Samuel Rymer Ophthalmology Department - Hospital de Clínicas de Porto Alegre Federal.
Endothelial Keratoplasty in Patients With an Anterior Chamber Intraocular Lens: A Montreal Experience Georges M. Durr, MD 1,2 Johanna Choremis, MD, FRCSC.
Tiago Lansini, MD ; Sergio Kwitko, PhD Authors have no financial interest in the subject matter of this poster.
Long-term outcomes of keratolimbal allografts and conjunctival limbal autografts for total limbal stem cell deficiency M. Ziaei MBChB (Hons), FRCOphth.
Miguel A. López M.D., María A. González Reiley M.D. The authors have no financial interest in the subject matter of this poster.
Urrets-Zavalia Syndrome After Lamellar Corneal Transplant: Two Case Reports Timothy Y. Chou, MD, Sujata P. Prabhu, MD, Justin Dexter, MD Department of.
Incidence of Cataract Extraction After Corneal Transplantation in Young and Middle-Aged Patients Revathi Naadimuthu, MD Gerald W. Zaidman, MD Brandon Mirochnik,
*Kagithane State Hospital,Department of Ophthalmology,Istanbul, Turkey DR.GÖKHAN KAYA *Kagithane State Hospital,Department of Ophthalmology, No author.
Daniel D. Hayes, MD1; Carolyn Y. Shih, MD1; David C
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
Corneal Tattooing with Amniotic Membrane Woo Chan Park M.D., Won Yeol Ryu M.D. Dept. of Ophthalmology, College of Medicine, Dong-A University Busan, Korea.
DSEK for the treatment of endothelial disease in India -Initial Experience in 80 eyes- Authors have no financial interest Dr Ashish Nagpal MD, FRCS Dr.
Elmira Baghdasaryan1,2, M.D. Sophie X. Deng1, M.D., Ph.D.
Yonca Aydin Akova MD, Leyla Erkanli Asena MD
UC Davis Long-Term Outcomes of the Boston Type I Keratoprosthesis Jennifer Li, M.D., Mark Greiner, M.D. Ana Carolina Vieira, M.D. Mark Mannis, M.D. University.
EXPERIENCE WITH A PMMA KERATOPROSTHESIS AT THE FEDERAL UNIVERSITY OF SAO PAULO, BRASIL Oliveira LA, M.D; Sousa LB, M.D; Hofling-Lima AL, M.D; Freitas D,
The Use of a PMMA Keratoprosthesis in Severe Ocular Chemical Burn Fabiano Cade, Allyson Tauber, Claes H. Dohlman Massachusetts Eye and Ear Infirmary Harvard.
Cost-Effectiveness of the Type II Boston Keratoprosthesis Jared D. Ament, MD, MPH, Tomasz P. Stryjewski, BS, Siddharth Pujari, PhD, George Papaliodus,
Date of download: 6/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Outcomes of Keratolimbal Allograft for Total.
Modified Osteo-Odonto Keratoprosthesis (MOOKP) in patients with severe anterior segment disease: Our Hong Kong Experience Bone – Tooth Cornea replacement.
Collagen Cross-Linking in Early Keratoconus: Before and After
Role of HSV Infection in the Histopathology of Failed DSAEK
Imaging the Posterior Segment Through a PMMA Keratoprosthesis
I-Chan Lin MD, Paul P. Lee MD, JD
Presentation transcript:

Assessing the Role of Soft Contact Lenses in Preoperative Conditions Following Keratoprosthesis Implantation The authors have no financial interest in the subject matter of this poster. Leah L. Kammerdiener, Miranda Lynch, Mona Harissi-Dagher, Claes H. Dohlman, James Aquavella, Joseph B. Ciolino, James Chodosh Massachusetts Eye and Ear Infirmary, University of Rochester Flaum Eye Institute

The keratoprosthesis (Kpro), an artificial cornea, has proven effective at establishing a clear pathway for light through an opaque cornea. 1 To qualify for the procedure, patients who underwent KPro surgery had poor prognoses for simple penetrating keratoplasty. These included patients with multiple graft rejection (54%), chemical injury (15%), and herpes simplex virus keratitis (7%) among others. 2 The quality of life of the patients was increased with the restoration of vision, in some cases from light perception only to 20/400 vision 1. INTRODUCTON

Some of the difficulties arising from the KPro surgery have been desiccation by evaporative forces, epithelial defects, stromal thinning, and dellen formation. 3 Problems caused by the physical presence of the device include instability of the KPro and aqueous humor leakage. 4 To help protect the cornea from some of these complications, a soft contact lens (SCL) is routinely placed as the last step of surgery. 3 The lens protects the corneal surface by diffusing the evaporative forces and maintaining a fluid meniscus at the edge of the front plate of the KPro. It also corrects postoperative refractive error, and can be used for cosmetic effect to match its paired eye. 3,5,6 Photos: Keratoprosthesis with overlying soft contact lens on slit lamp exam

It has been recognized that pre-operative categories of patients, most broadly divided into autoimmune disorders, chemical injury, and “other” can be prognostic of post-surgical visual acuity outcomes. 7 For the purposes of this study, the preoperative conditions have been grouped into autoimmune (Stevens- Johnson Syndrome, ocular cicatricial pemphigoid, rheumatoid arthritis, and uveitis), chemical injury, and “other” (infection and non-inflammatory conditions such as dystropheis, trauma, keratopathies, and keratoconus). There is however, a scarcity of data evaluating the pre-operative groups for prognostic value in the management of post-operative SCL use and complications.

To evaluate associations between patient pre-operative diagnosis with SCL retention, complications, and outcomes. A retrospective chart review was conducted of 92 patients’ (103 eyes) charts who underwent a Boston KPro Type I at the Massachusetts Eye and Ear Infirmary (MEEI) or the University of Rochester Flaum Eye Institute (UREI) by one of two surgeons (J.V.A, or C.H.D) between August 1995 and June The medical records were reviewed and analyzed for pre-operative diagnosis, past ocular surgical history, SCL retention, and subsequent complications and outcomes. PURPOSE METHODS

Preoperative categories included 16 patients with autoimmune disease (Stevens Johnson Syndrome, ocular cicatritial pemphigoid, rheumatoid arthritis, and uveitis), 9 with chemical injury, and 67 “other” (aniridia, infection, trauma, dystrophies, and keratopathies). Among these groups, the time to first soft contact lens (SCL) loss was shortest for chemical injury and longest for autoimmune patients. Figure: Time (in months) until first soft contact lens loss in each preoperative group. Vertical dashes mark where a censored data point occurs (time when patient follow-up ended, but no SCL loss was experienced). RESULTS

Chemical injury had more SCL losses while autoimmune had fewest. A small subset (n=17) of the population experienced more than 2 SCL losses per year. These patients comprised 6% of the autoimmune group, 22% of the chemical injury group, and 21% of the “other” group. Figure: Number of soft contact lens (SCL) losses per 10 years SCL wear.

Autoimmune experienced the highest yearly complication rate and “other” the lowest rate. Among all three categories, complication rates were highest when patients were not wearing their contact lenses. The most common complication experienced was corneal melt resulting in aqueous humor leak. Patients over the age of 70 years were significantly less likely to experience a complication compared to those younger than 70. Figure: Number of complications experienced while wearing SCL and without SCL per 10 patient- years of follow-up.

Even with a trend toward higher lens retention, some patients with autoimmune disease are destined to develop corneal complications after implantation. The chronic inflammatory response present in eyes affected by autoimmune diseases is responsible for increased complication rates, predisposing the corneal surface to sterile corneal ulcers and infections. 6 Chemically injured eyes experienced the most rapid initial soft contact lens loss which may be due to poor tear production, ocular surface disease, symblepharon formation, and lid abnormalities that are associated with these injuries. 8 Non-autoimmune and non-chemical injury patients may have less inflammation, and typically have normal tear production and normal eyelid function. The difficulty in lens fitting in some non-chemical injury and non-autoimmune disorder patients may account for the slightly higher rate of contact lens loss. CONCLUSION

1 Aquavella, JV., Y. Qian, GJ. McCormick, and JR. Palakuru. "Keratoprosthesis: The Dohlman-Doane Device." American Journal of Ophthalmology 6 (2005): Zerbe, B., M. Belin, and J. Ciolino. "Results from the Multicenter Boston Type 1 Keratoprosthesis Study." Ophthalmology 113 (2006): Harissi-Dagher, M., J. Beyer, and CH. Dohlman. "The Role of Soft Contact Lenses as an Adjunct to the Boston Keratoprothesis." International Opthalmology Clinic 2 (2008): Khan, BF., M. Harissi-Dagher, DM. Khan, and CH. Dohlman. "Advances in Boston Keratoprosthesis: Enhancing Retention and Prevention of Infection and Inflammation." International Ophthalmology Clinic 2 (2007): Macsai, MS. "The Management of Corneal Trauma: Advances in the Past Twenty-five Year." Cornea 5 (2000): Dohlman, CH., EJ. Dudenhoefer, BF. Khan, and S. Morneault. "Protection of the Ocular Surface After Keratoprosthesis Surgery: The Role of Soft Contact Lenses." CLAO J. 2 (2002): Yaghouti, F., M. Nouri, JC. Abad, WJ. Power, MG. Doane, CH. Dohlman. “Keratoprothesis: Preoperative Prognostic Categories.” Cornea 20 (2001): There are no commercial relationships or any financial disclosures. 8 Kadar T, Dachir S, Cohen L, et al. Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy. Toxicology. Sep ;263(1): REFERENCES